Key facts
- It has raised $420K; the latest was Later Stage VC in Feb 2025.
- Notable investors include Bpifrance, Entrepreneurs First, EIT Food, StartLife, AgFunder — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Plantik
- ·The full record, as it builds
Funding rounds
No funding rounds for Plantik are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Plantik
Developer of plant biotechnology solutions designed to create climate-resilient crops. The company leverages genomic data and advanced plant engineering workflows to explore underutilized genetic variation in plants, enabling the development of crops with enhanced resilience traits such as thermotolerance to withstand heat stress and changing environmental conditions, supporting improved agricultural productivity and food security.
- Sector
- Healthcare
- HQ
- Paris, France
- Founded
- 2019
- Employees
- 8
- Website
- plantik.bio/
- Ownership
- Privately Held (backing)
Plantik doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Plantik shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Plantik in its N-PORT filings yet. We sweep new filings monthly.